APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Drug and Device Microbiological Sterility Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Medical Drug and Device Microbiological Sterility Testing Market Analysis and Forecast 2026-2032

6 March 2026198 pages

Choose your research edition.

Industry ResearchMedical Drug and Device Microbiological Sterility Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Drug and Device Microbiological Sterility Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Medical Drug and Device Microbiological Sterility Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Drug and Device Microbiological Sterility Testing Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Drug and Device Microbiological Sterility Testing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Medical Drug and Device Microbiological Sterility Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medical Drug and Device Microbiological Sterility Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medical Drug and Device Microbiological Sterility Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medical Drug and Device Microbiological Sterility Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medical Drug and Device Microbiological Sterility Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medical Drug and Device Microbiological Sterility Testing include Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings and Almac Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medical Drug and Device Microbiological Sterility Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Drug and Device Microbiological Sterility Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Drug and Device Microbiological Sterility Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Drug and Device Microbiological Sterility Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Drug and Device Microbiological Sterility Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Drug and Device Microbiological Sterility Testing revenue, projected growth trends, production technology, application and end-user industry.

Medical Drug and Device Microbiological Sterility Testing Segment by Company

Steris PLC

Charles River Laboratories International, Inc.

Thermo Fisher Scientific, Inc.

SGS S.A.

Sartorius AG

Sotera Health Company

Pacific Biolabs, Inc.

Laboratory Corporation of America Holdings

Almac Group

Pace Analytical Services, LLC

Medical Drug and Device Microbiological Sterility Testing Segment by Type

Bioburden Testing

Sterility Testing

Bacterial Endotoxin Testing

Medical Drug and Device Microbiological Sterility Testing Segment by Application

Medical Drugs

Medical Devices

Medical Drug and Device Microbiological Sterility Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Drug and Device Microbiological Sterility Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Drug and Device Microbiological Sterility Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Drug and Device Microbiological Sterility Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Drug and Device Microbiological Sterility Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Drug and Device Microbiological Sterility Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Drug and Device Microbiological Sterility Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bioburden Testing Major Player Table 3. Sterility Testing Major Player Table 4. Bacterial Endotoxin Testing Major Player Table 5. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Medical Drugs Major Player Table 7. Medical Devices Major Player Table 8. Medical Drug and Device Microbiological Sterility Testing Industry Trends Table 9. Medical Drug and Device Microbiological Sterility Testing Industry Drivers Table 10. Medical Drug and Device Microbiological Sterility Testing Industry Opportunities and Challenges Table 11. Medical Drug and Device Microbiological Sterility Testing Industry Restraints Table 12. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Medical Drug and Device Microbiological Sterility Testing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Medical Drug and Device Microbiological Sterility Testing Market Share by Region (2021-2026) Table 15. Global Medical Drug and Device Microbiological Sterility Testing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Medical Drug and Device Microbiological Sterility Testing Market Share by Region (2027-2032) Table 17. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Players (2021-2026) Table 19. Global Medical Drug and Device Microbiological Sterility Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Medical Drug and Device Microbiological Sterility Testing Key Players Headquarters & Area Served Table 21. Global Medical Drug and Device Microbiological Sterility Testing Players, Product Type & Application Table 22. Global Medical Drug and Device Microbiological Sterility Testing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Medical Drug and Device Microbiological Sterility Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Type (2021-2026) Table 29. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Type (2027-2032) Table 30. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Application (2021-2026) Table 34. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Application (2027-2032) Table 35. Steris PLC Company Information Table 36. Steris PLC Business Overview Table 37. Steris PLC Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Steris PLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 39. Steris PLC Recent Development Table 40. Charles River Laboratories International, Inc. Company Information Table 41. Charles River Laboratories International, Inc. Business Overview Table 42. Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 44. Charles River Laboratories International, Inc. Recent Development Table 45. Thermo Fisher Scientific, Inc. Company Information Table 46. Thermo Fisher Scientific, Inc. Business Overview Table 47. Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 49. Thermo Fisher Scientific, Inc. Recent Development Table 50. SGS S.A. Company Information Table 51. SGS S.A. Business Overview Table 52. SGS S.A. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. SGS S.A. Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 54. SGS S.A. Recent Development Table 55. Sartorius AG Company Information Table 56. Sartorius AG Business Overview Table 57. Sartorius AG Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Sartorius AG Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 59. Sartorius AG Recent Development Table 60. Sotera Health Company Company Information Table 61. Sotera Health Company Business Overview Table 62. Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 64. Sotera Health Company Recent Development Table 65. Pacific Biolabs, Inc. Company Information Table 66. Pacific Biolabs, Inc. Business Overview Table 67. Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 69. Pacific Biolabs, Inc. Recent Development Table 70. Laboratory Corporation of America Holdings Company Information Table 71. Laboratory Corporation of America Holdings Business Overview Table 72. Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 74. Laboratory Corporation of America Holdings Recent Development Table 75. Almac Group Company Information Table 76. Almac Group Business Overview Table 77. Almac Group Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Almac Group Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 79. Almac Group Recent Development Table 80. Pace Analytical Services, LLC Company Information Table 81. Pace Analytical Services, LLC Business Overview Table 82. Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 84. Pace Analytical Services, LLC Recent Development Table 85. North America Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Medical Drug and Device Microbiological Sterility Testing Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Country (US$ Million) & (2027-2032) Table 99. China Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 100. China Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 101. China Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 102. China Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Medical Drug and Device Microbiological Sterility Testing Image Figure 2. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Drug and Device Microbiological Sterility Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bioburden Testing Image Figure 5. Sterility Testing Image Figure 6. Bacterial Endotoxin Testing Image Figure 7. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Medical Drug and Device Microbiological Sterility Testing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Medical Drugs Image Figure 10. Medical Devices Image Figure 11. Global Medical Drug and Device Microbiological Sterility Testing Market Size (US$ Million) & (2021-2032) Figure 12. Global Medical Drug and Device Microbiological Sterility Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Medical Drug and Device Microbiological Sterility Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Medical Drug and Device Microbiological Sterility Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Type (2021-2032) Figure 19. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Application (2021-2032) Figure 22. North America Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032) Figure 24. North America Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032) Figure 25. North America Medical Drug and Device Microbiological Sterility Testing Revenue Share by Country (2021-2032) Figure 26. United States Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032) Figure 31. Europe Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032) Figure 32. Europe Medical Drug and Device Microbiological Sterility Testing Revenue Share by Country (2021-2032) Figure 33. Germany Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032) Figure 43. China Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032) Figure 44. Asia Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032) Figure 46. Asia Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032) Figure 47. Asia Medical Drug and Device Microbiological Sterility Testing Revenue Share by Region (2021-2032) Figure 48. Japan Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032) Figure 56. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032) Figure 57. SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue Share by Country (2021-2032) Figure 58. Brazil Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Medical Drug and Device Microbiological Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Bioburden Testing
  • Sterility Testing
  • Bacterial Endotoxin Testing
Applications
  • Medical Drugs
  • Medical Devices
Companies covered
  • Steris PLC
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • SGS S.A.
  • Sartorius AG
  • Sotera Health Company
  • Pacific Biolabs, Inc.
  • Laboratory Corporation of America Holdings
  • Almac Group
  • Pace Analytical Services, LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Drug and Device Microbiological Sterility Testing Market by Type
  3. 1.2.1 Global Medical Drug and Device Microbiological Sterility Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bioburden Testing
  5. 1.2.3 Sterility Testing
  6. 1.2.4 Bacterial Endotoxin Testing
  7. 1.3 Medical Drug and Device Microbiological Sterility Testing Market by Application
  8. 1.3.1 Global Medical Drug and Device Microbiological Sterility Testing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Medical Drugs
  10. 1.3.3 Medical Devices
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Medical Drug and Device Microbiological Sterility Testing Market Dynamics
  1. 2.1 Medical Drug and Device Microbiological Sterility Testing Industry Trends
  2. 2.2 Medical Drug and Device Microbiological Sterility Testing Industry Drivers
  3. 2.3 Medical Drug and Device Microbiological Sterility Testing Industry Opportunities and Challenges
  4. 2.4 Medical Drug and Device Microbiological Sterility Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Drug and Device Microbiological Sterility Testing Market Perspective (2021-2032)
  2. 3.2 Global Medical Drug and Device Microbiological Sterility Testing Growth Trends by Region
  3. 3.2.1 Global Medical Drug and Device Microbiological Sterility Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Drug and Device Microbiological Sterility Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Drug and Device Microbiological Sterility Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Players
  2. 4.1.1 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Drug and Device Microbiological Sterility Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Drug and Device Microbiological Sterility Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Drug and Device Microbiological Sterility Testing Key Players Headquarters & Area Served
  7. 4.4 Global Medical Drug and Device Microbiological Sterility Testing Players, Product Type & Application
  8. 4.5 Global Medical Drug and Device Microbiological Sterility Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Drug and Device Microbiological Sterility Testing Market CR5 and HHI
  11. 4.6.3 2025 Medical Drug and Device Microbiological Sterility Testing Tier 1, Tier 2, and Tier 3
5 Medical Drug and Device Microbiological Sterility Testing Market Size by Type
  1. 5.1 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2032)
  3. 5.3 Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Type (2021-2032)
6 Medical Drug and Device Microbiological Sterility Testing Market Size by Application
  1. 6.1 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2032)
  3. 6.3 Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Steris PLC
  2. 7.1.1 Steris PLC Company Information
  3. 7.1.2 Steris PLC Business Overview
  4. 7.1.3 Steris PLC Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Steris PLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  6. 7.1.5 Steris PLC Recent Developments
  7. 7.2 Charles River Laboratories International, Inc.
  8. 7.2.1 Charles River Laboratories International, Inc. Company Information
  9. 7.2.2 Charles River Laboratories International, Inc. Business Overview
  10. 7.2.3 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  12. 7.2.5 Charles River Laboratories International, Inc. Recent Developments
  13. 7.3 Thermo Fisher Scientific, Inc.
  14. 7.3.1 Thermo Fisher Scientific, Inc. Company Information
  15. 7.3.2 Thermo Fisher Scientific, Inc. Business Overview
  16. 7.3.3 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  18. 7.3.5 Thermo Fisher Scientific, Inc. Recent Developments
  19. 7.4 SGS S.A.
  20. 7.4.1 SGS S.A. Company Information
  21. 7.4.2 SGS S.A. Business Overview
  22. 7.4.3 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  24. 7.4.5 SGS S.A. Recent Developments
  25. 7.5 Sartorius AG
  26. 7.5.1 Sartorius AG Company Information
  27. 7.5.2 Sartorius AG Business Overview
  28. 7.5.3 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  30. 7.5.5 Sartorius AG Recent Developments
  31. 7.6 Sotera Health Company
  32. 7.6.1 Sotera Health Company Company Information
  33. 7.6.2 Sotera Health Company Business Overview
  34. 7.6.3 Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  36. 7.6.5 Sotera Health Company Recent Developments
  37. 7.7 Pacific Biolabs, Inc.
  38. 7.7.1 Pacific Biolabs, Inc. Company Information
  39. 7.7.2 Pacific Biolabs, Inc. Business Overview
  40. 7.7.3 Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  42. 7.7.5 Pacific Biolabs, Inc. Recent Developments
  43. 7.8 Laboratory Corporation of America Holdings
  44. 7.8.1 Laboratory Corporation of America Holdings Company Information
  45. 7.8.2 Laboratory Corporation of America Holdings Business Overview
  46. 7.8.3 Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  48. 7.8.5 Laboratory Corporation of America Holdings Recent Developments
  49. 7.9 Almac Group
  50. 7.9.1 Almac Group Company Information
  51. 7.9.2 Almac Group Business Overview
  52. 7.9.3 Almac Group Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Almac Group Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  54. 7.9.5 Almac Group Recent Developments
  55. 7.10 Pace Analytical Services, LLC
  56. 7.10.1 Pace Analytical Services, LLC Company Information
  57. 7.10.2 Pace Analytical Services, LLC Business Overview
  58. 7.10.3 Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  60. 7.10.5 Pace Analytical Services, LLC Recent Developments
8 North America
  1. 8.1 North America Medical Drug and Device Microbiological Sterility Testing Revenue (2021-2032)
  2. 8.2 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032)
  5. 8.3 North America Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032)
  9. 8.5 North America Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Country
  11. 8.6.1 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Drug and Device Microbiological Sterility Testing Revenue (2021-2032)
  2. 9.2 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Country
  11. 9.6.1 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Drug and Device Microbiological Sterility Testing Revenue (2021-2032)
  2. 10.2 China Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032)
  5. 10.3 China Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032)
  9. 10.5 China Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Drug and Device Microbiological Sterility Testing Revenue (2021-2032)
  2. 11.2 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Country
  11. 11.6.1 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue (2021-2032)
  2. 12.2 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Country
  11. 12.6.1 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Drug and Device Microbiological Sterility Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst